January 07, 2015
Aerocrine Reports Record Sales for the 4th Quarter and Full Year 2014
Media
January 07, 2015
Ultragenyx Announces License of Intellectual Property Related to the Treatment of Huntington’s Disease With Triheptanoin
January 06, 2015
Ultragenyx Initiates New Development Program Studying KRN23 for the Treatment of Tumor-Induced Osteomalacia
December 30, 2014
Orexo issues a SEK 500 million bond loan on the Swedish bond market
December 30, 2014
Ultragenyx Announces Positive Data From Phase 2 Study of Sialic Acid Extended-Release
December 30, 2014
NephroGenex Announces Positive Results For QT Study Of Pyridorin
December 27, 2014
Orexo commences patent infringement litigation against Actavis
December 27, 2014
Nexstim stroke treatment covered by US TV channels
December 27, 2014
Ultragenyx announces positive preliminary data from phase I/II study
December 27, 2014
Betalutin™ Successful Completion of Phase I Part of Phase I/II Study